BICARA THERAPEUTICS Equity (BCAX) insider trading activity (SEC Form 4). Over the trailing 90 days, BCAX insiders filed 0 purchases totalling $0 and 5 sales totalling $2.4M — net SELLING of $2.4M. Most recent filing: Jul 14, 2026. Insider transactions are a Pro-tier alertable signal in the live Top Tier Newswire terminal — Form 4 filings reach the wire within minutes of acceptance by the SEC. Data shown publicly here is delayed 4 hours.
| Filed | Insider | Role | Type | Shares | Price | Value | |
|---|---|---|---|---|---|---|---|
| Jul 14, 2026 | Mazumdar Claire | CEO | S SaleOE | — | $28.42 | $284K | filing |
| Jul 10, 2026 | Cohlhepp Ryan | Pres, COO | S SaleOE | — | $28.98 | $833K | filing |
| Jul 10, 2026 | Hyep Ivan | CFO | S SaleOE | — | $28.85 | $808K | filing |
| May 26, 2026 | Hyep Ivan | CFO | S SaleOE | — | $20.42 | $188K | filing |
| May 18, 2026 | Cohlhepp Ryan | Pres, COO | S SaleOE | — | $20.29 | $254K | filing |